PLA2G2A and congenital thrombotic thrombocytopenic purpura: Given our hypothesis that PLA2G2A is a marker of TMA and microangiopathic hemolytic anemia, we examined whether levels of PLA2G2A correlated to lowest platelet count and lowest hemoglobin during admission.